Clinical Trials Browser

Developmental Disabilities, Communication Disorders, Deglutition Disorders, Head and Neck Neoplasms, Language Development Disorders, Language Disorders, Speech, Stuttering, Hearing Loss

NCT01864291 2020-06-02

ABI

Phase NA Terminated

9 enrolled 10 charts

Deafness, Hearing Loss

NCT01736267 2020-05-06

Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects

Phase NA Terminated

3 enrolled 8 charts

Deafness, Hearing Loss

NCT01451853 2017-09-25

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Phase 2 Unknown

80 enrolled

Head & NeckThoracic

Ototoxicity, Deafness, Head and Neck Neoplasms, Lung Neoplasms, Tinnitus, Hearing Loss

NCT01969370 2017-05-03

NCGENES

Phase NA Completed

645 enrolled

Congenital Abnormalities, Cardiovascular Diseases, Neoplasms, Neurologic Manifestations, Neurodegenerative Diseases, Hearing Loss

NCT01452607 2016-06-29

Study to Evaluate the Safety and Pharmacokinetics of SPI-1005

Phase 1 Completed

32 enrolled

Neoplasms, Hearing Loss

NCT00584155 2015-05-27

Protection From Cisplatin Ototoxicity by Lactated Ringers

Phase 1 Withdrawn

Ear Neoplasms, Hearing Loss

NCT00004437 2015-03-25

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

Phase 2 Completed

CNS

Mental Disorders, Neurologic Manifestations, Neuroma, Acoustic, Neurofibromatosis 2, Neurofibromatoses, Genetic Diseases, Inborn, Hearing Loss, Rare Diseases

Clinical Trials

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

HEAR

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves

HSA50+

SSNHL in Head & Neck Cancer Patients

MRI-based Synthetic CT Images of the Head and Neck

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

NAC to Prevent Cisplatin-induced Hearing Loss

Treatment and Prevention of Middle Ear Morbidity in Head and Neck Cancer Patients Following Radiotherapy

Providing Speech Therapy Awareness in Private Schools

ABI